B. Riley Securities Maintains Buy on WAVE Life Sciences, Raises Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has maintained a Buy rating on WAVE Life Sciences and increased the price target from $11 to $19, indicating a positive outlook for the company's stock.
October 03, 2024 | 1:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
B. Riley Securities has maintained a Buy rating on WAVE Life Sciences and increased the price target from $11 to $19, suggesting a positive short-term outlook for the stock.
The increase in the price target from $11 to $19 by B. Riley Securities indicates a strong positive sentiment towards WAVE Life Sciences. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100